Trevi Therapeutics Inc (TRVI) Implied Volatility Current

Tracking TRVI implied volatility helps you identify when options premiums on Trevi Therapeutics Inc are historically cheap or expensive, and where the best trades are hiding. Trevi Therapeutics Inc implied volatility reflects the market's expectation of future price movement: when TRVI IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Trevi Therapeutics Inc's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For TRVI, tracking metrics like TRVI IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on TRVI signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of Haduvio to treat serious neurologically mediated conditions. The company is developing Haduvio, an oral extended-release formulation of nalbuphine, which is in phase IIb/III clinical trial for the treatment of chronic pruritus, chronic cough in patients with idiopathic pulmonary fibrosis. It has a license agreement with Endo Pharmaceuticals Inc. to develop and commercialize products incorporating nalbuphine hydrochloride in any formulation. The company was incorporated in 2011 and is headquartered in New Haven, Connecticut.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where TRVI implied volatility sits today versus where it has been. Our scanner ranks Trevi Therapeutics Inc implied volatility against its historical range, surfaces extremes in TRVI IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Trevi Therapeutics Inc IV is rich or cheap — measure it, then act on it.